IMC Chicago
ALXN

IMC Chicago’s Alexion Pharmaceuticals ALXN Stock Holding History

IMC Chicago’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-189,100
Closed -$29.5M – 1223
2020
Q4 		$29.5M Buy
+189,100
New +$24.3M 0.04% 201
2020
Q1 		– Sell
-20,700
Closed -$2.24M – 955
2019
Q4 		$2.24M Buy
20,700
+5,000
+32% +$535K 0.01% 499
2019
Q3 		$1.54M Sell
15,700
-3,900
-20% -$440K ﹤0.01% 504
2019
Q2 		$2.57M Sell
19,600
-5,600
-22% -$722K 0.01% 375
2019
Q1 		$3.41M Buy
25,200
+8,000
+47% +$995K 0.01% 291
2018
Q4 		$1.68M Buy
+17,200
New +$2.03M 0.01% 373

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return